Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition Inv. presentation Quarterly results Director comp. Appointed director
|
23andMe Holding Co.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/06/2023 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Sold 38,548 shares
@ $0.8407, valued at
$32.4k
Exercised 38,548 options to buy
@ $0.42, valued at
$16.2k
|
|
08/25/2023 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Sold 40,894 shares
@ $1.0544, valued at
$43.1k
Exercised 40,894 options to buy
@ $0.42, valued at
$17.2k
|
|
08/22/2023 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Paid exercise price by delivering 4,628 shares
@ $1.14, valued at
$5.3k
|
|
08/22/2023 |
4
| Selsavage Joseph Anthony (Interim CFO) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Paid exercise price by delivering 6,209 shares
@ $1.14, valued at
$7.1k
|
|
08/22/2023 |
4
| Richards William G (Head of Therapeutics Discovery) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Paid exercise price by delivering 8,185 shares
@ $1.14, valued at
$9.3k
|
|
08/16/2023 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Sold 40,894 shares
@ $1.319, valued at
$53.9k
Exercised 40,894 options to buy
@ $0.42, valued at
$17.2k
|
|
07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/30/2023 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Sold 40,894 shares
@ $1.7223, valued at
$70.4k
Exercised 40,894 options to buy
@ $0.42, valued at
$17.2k
|
|
06/07/2023 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Granted 43,659 shares
@ $0 Paid exercise price by delivering 15,098 shares
@ $2.08, valued at
$31.4k
|
|
06/07/2023 |
4
| Hillan Kenneth J. (Chief Therapeutics Officer) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Granted 44,381 shares
@ $0 Paid exercise price by delivering 15,347 shares
@ $2.08, valued at
$31.9k
|
|
06/07/2023 |
4
| Selsavage Joseph Anthony (Interim CFO) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Granted 37,808 shares
@ $0 Paid exercise price by delivering 13,075 shares
@ $2.08, valued at
$27.2k
|
|
05/23/2023 |
4
| Selsavage Joseph Anthony (Interim CFO) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Paid exercise price by delivering 6,209 shares
@ $1.94, valued at
$12k
|
|
05/23/2023 |
4
| Hillan Kenneth J. (Chief Therapeutics Officer) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Paid exercise price by delivering 4,628 shares
@ $1.94, valued at
$9k
|
|
05/23/2023 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Paid exercise price by delivering 4,628 shares
@ $1.94, valued at
$9k
|
|
02/22/2023 |
4
| Hillan Kenneth J. (Chief Therapeutics Officer) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Paid exercise price by delivering 5,457 shares
@ $2.87, valued at
$15.7k
|
|
02/22/2023 |
4
| Selsavage Joseph Anthony (Interim CFO) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Paid exercise price by delivering 7,321 shares
@ $2.87, valued at
$21k
|
|
02/22/2023 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Paid exercise price by delivering 5,457 shares
@ $2.87, valued at
$15.7k
|
|
12/06/2022 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Sold 26,259 shares
@ $3.25, valued at
$85.3k
|
|
11/22/2022 |
4
| Selsavage Joseph Anthony (Interim CFO) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Paid exercise price by delivering 10,105 shares
@ $2.99, valued at
$30.2k
|
|
11/22/2022 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Paid exercise price by delivering 4,628 shares
@ $2.99, valued at
$13.8k
|
|
11/22/2022 |
4
| Hillan Kenneth J. (Chief Therapeutics Officer) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Paid exercise price by delivering 4,628 shares
@ $2.99, valued at
$13.8k
|
|
09/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/08/2022 |
4
| Hernandez Sandra R MD (Director) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Granted 14,633 shares
@ $0 Granted 3,251 shares
@ $3.08, valued at
$10k
|
|
09/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/29/2022 |
4
| Hernandez Sandra R MD (Director) has filed a Form 4 on 23andMe Holding Co.
Txns:
| Granted 57,755 shares
@ $0 Granted 13,201 shares
@ $3.03, valued at
$40k
|
|
08/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|